Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers
Study Details
Study Description
Brief Summary
The purpose of this study was to assess comfort in soft contact lens wearers.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: OPTI-FREE RepleniSH OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. |
Device: OPTI-FREE RepleniSH multipurpose disinfecting solution
FDA-approved, multipurpose disinfecting solution used according to provided instructions for cleaning, rinsing, storing, and disinfecting study contact lenses on a daily basis, 2 weeks.
Other Names:
Device: Contact lenses
Contact lenses per subject's habitual brand and prescription worn every day for the duration of the study, 14 days, on a daily wear basis without scheduled replacement.
|
Active Comparator: Clear Care Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. |
Device: Clear Care contact lens care system
FDA-approved, hydrogen peroxide-based, lens care system used according to provided instructions for cleaning, disinfecting, daily protein removing, and storage of study contact lenses on a daily basis, 2 weeks.
Other Names:
Device: Contact lenses
Contact lenses per subject's habitual brand and prescription worn every day for the duration of the study, 14 days, on a daily wear basis without scheduled replacement.
|
Outcome Measures
Primary Outcome Measures
- Change From Baseline in Ocular Comfort Rating at 2 Weeks [Baseline (Day 0), 2 weeks]
Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now."
- Likert Questionnaire Scores at 2 Weeks [2 weeks]
The Likert Questionnaire included 8 questions on selected comfort measures. All responses were recorded on a 5-point scale, where 1=Strongly Disagree, 2=Disagree, 3=Undecided, 4=Agree, and 5=Strongly Agree.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Wear silicone hydrogel contact lenses on a daily wear basis;
-
Currently using OPTI-FREE RepleniSH contact lens solution;
-
Report comfort above 75 on a Visual Analog Scale at the Baseline Visit;
-
Read, sign, and date IRB-approved informed consent and the privacy document;
-
Be generally healthy and have normal ocular health;
-
Be be willing to follow the study procedures and visit schedule;
-
Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
-
Use of additional lens cleaners;
-
Known sensitivity to any ingredient in either of the test articles;
-
Systemic or ocular disease or disorder (except refractive error) that would negatively affect the conduct or outcome of the study;
-
Prior (within 7 days of enrollment) or current ocular infections;
-
Clinically significant lash or lid abnormality;
-
History of ocular surgery/trauma within the last 6 months;
-
Use of any topical ocular or systemic antibiotics or corticosteroids within 7 days of enrollment;
-
Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollment;
-
Other protocol-defined exclusion criteria may apply.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Alcon Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SMA-09-58
Study Results
Participant Flow
Recruitment Details | Participants were recruited from two US study centers. |
---|---|
Pre-assignment Detail |
Arm/Group Title | OPTI-FREE RepleniSH | Clear Care |
---|---|---|
Arm/Group Description | OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. | Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. |
Period Title: Overall Study | ||
STARTED | 39 | 39 |
COMPLETED | 37 | 38 |
NOT COMPLETED | 2 | 1 |
Baseline Characteristics
Arm/Group Title | OPTI-FREE RepleniSH | Clear Care | Total |
---|---|---|---|
Arm/Group Description | OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. | Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. | Total of all reporting groups |
Overall Participants | 39 | 39 | 78 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
37.1
(12.27)
|
41.5
(9.59)
|
39.3
(11.16)
|
Sex: Female, Male (Count of Participants) | |||
Female |
29
74.4%
|
26
66.7%
|
55
70.5%
|
Male |
10
25.6%
|
13
33.3%
|
23
29.5%
|
Region of Enrollment (participants) [Number] | |||
United States |
39
100%
|
39
100%
|
78
100%
|
Outcome Measures
Title | Change From Baseline in Ocular Comfort Rating at 2 Weeks |
---|---|
Description | Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now." |
Time Frame | Baseline (Day 0), 2 weeks |
Outcome Measure Data
Analysis Population Description |
---|
All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations. |
Arm/Group Title | OPTI-FREE RepleniSH | Clear Care |
---|---|---|
Arm/Group Description | OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. | Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. |
Measure Participants | 37 | 38 |
Least Squares Mean (95% Confidence Interval) [Units on a scale] |
-8.20
|
-7.14
|
Title | Likert Questionnaire Scores at 2 Weeks |
---|---|
Description | The Likert Questionnaire included 8 questions on selected comfort measures. All responses were recorded on a 5-point scale, where 1=Strongly Disagree, 2=Disagree, 3=Undecided, 4=Agree, and 5=Strongly Agree. |
Time Frame | 2 weeks |
Outcome Measure Data
Analysis Population Description |
---|
All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations. |
Arm/Group Title | OPTI-FREE RepleniSH | Clear Care |
---|---|---|
Arm/Group Description | OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. | Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. |
Measure Participants | 37 | 38 |
I can comfortably wear my lenses |
4.20
|
4.24
|
My lenses stay moist from morning to evening |
3.60
|
3.69
|
The solution I use feels gentle on my eyes |
4.00
|
3.66
|
My lenses feel fresh |
3.79
|
4.03
|
At the end of the day, my vision is clear |
3.54
|
3.86
|
When I put my lenses in, they feel comfortable |
4.05
|
4.03
|
I like the way this product feels during handling |
4.09
|
3.66
|
My lenses feel moist |
3.84
|
3.64
|
Adverse Events
Time Frame | Adverse events were collected for the duration of the study: 5 months, 3 weeks. | |||
---|---|---|---|---|
Adverse Event Reporting Description | The safety population included all enrolled and exposed participants. | |||
Arm/Group Title | OPTI-FREE RepleniSH | Clear Care | ||
Arm/Group Description | OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. | Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. | ||
All Cause Mortality |
||||
OPTI-FREE RepleniSH | Clear Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
OPTI-FREE RepleniSH | Clear Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/39 (0%) | 0/39 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
OPTI-FREE RepleniSH | Clear Care | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/39 (0%) | 0/39 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
Alcon reserves the right of prior review of any publication or presentation of information related to the study.
Results Point of Contact
Name/Title | Jami Kern, Ph.D. |
---|---|
Organization | Alcon Global Medical Affairs |
Phone | 1-888-451-3937 |
- SMA-09-58